TELETRADER News
8/18/2020, 10:30 AM (Source: TeleTrader)
more TeleTrader news

Oxford's vaccine in phase 3 of trial in India

The coronavirus vaccine developed by AstraZeneca PLC and the University of Oxford will start the third phase of the trial in Mumbai, the Serum Institute of India revealed on Tuesday.

The vaccine, named Covidshield in India, will be tested in two hospitals in Mumbai, on a sample of 320 people aged 20-50.

A month ago, AstraZeneca released a preliminary research report revealing that its vaccine candidate produces an appropriate immune response and is safe for use.

Breaking the News / BU